1 Answers
Dr. Shoyeb
এমবিবিএস
,
পিজিটি(মেডিসিন)
,
সিসিডি(বারডেম)
,
সিএমইউ
Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for:
- Ovarian cancer: After failure of platinum-based chemotherapy.
- AIDS-related Kaposi’s Sarcoma: After failure of prior systemic chemotherapy or intolerance to such therapy.
- Multiple Myeloma: In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.
Doxorub IV Injection সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Doxorub
3549 views
Answered